Highlights

[PHARMA] YoY TTM Result on 2011-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 22-Feb-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 31-Dec-2011  [#4]
Profit Trend QoQ -     37.40%    YoY -     71.66%
Quarter Report


View:


Show?  YoY % Horiz. %

TTM Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 2,122,933 1,946,639 1,812,346 1,520,981 1,378,348 1,300,796 1,305,646 8.43%
  YoY % 9.06% 7.41% 19.16% 10.35% 5.96% -0.37% -
  Horiz. % 162.60% 149.09% 138.81% 116.49% 105.57% 99.63% 100.00%
PBT 125,580 92,997 103,314 73,186 45,462 81,438 90,599 5.59%
  YoY % 35.04% -9.99% 41.17% 60.98% -44.18% -10.11% -
  Horiz. % 138.61% 102.65% 114.03% 80.78% 50.18% 89.89% 100.00%
Tax -31,355 -36,236 -40,108 -20,401 -15,152 -19,709 -29,190 1.20%
  YoY % 13.47% 9.65% -96.60% -34.64% 23.12% 32.48% -
  Horiz. % 107.42% 124.14% 137.40% 69.89% 51.91% 67.52% 100.00%
NP 94,225 56,761 63,206 52,785 30,310 61,729 61,409 7.39%
  YoY % 66.00% -10.20% 19.74% 74.15% -50.90% 0.52% -
  Horiz. % 153.44% 92.43% 102.93% 85.96% 49.36% 100.52% 100.00%
NP to SH 93,844 55,200 61,711 52,157 30,384 60,192 60,031 7.73%
  YoY % 70.01% -10.55% 18.32% 71.66% -49.52% 0.27% -
  Horiz. % 156.33% 91.95% 102.80% 86.88% 50.61% 100.27% 100.00%
Tax Rate 24.97 % 38.96 % 38.82 % 27.88 % 33.33 % 24.20 % 32.22 % -4.16%
  YoY % -35.91% 0.36% 39.24% -16.35% 37.73% -24.89% -
  Horiz. % 77.50% 120.92% 120.48% 86.53% 103.45% 75.11% 100.00%
Total Cost 2,028,708 1,889,878 1,749,140 1,468,196 1,348,038 1,239,067 1,244,237 8.49%
  YoY % 7.35% 8.05% 19.14% 8.91% 8.79% -0.42% -
  Horiz. % 163.05% 151.89% 140.58% 118.00% 108.34% 99.58% 100.00%
Net Worth 525,351 486,672 472,037 514,153 421,262 431,217 388,298 5.16%
  YoY % 7.95% 3.10% -8.19% 22.05% -2.31% 11.05% -
  Horiz. % 135.30% 125.33% 121.57% 132.41% 108.49% 111.05% 100.00%
Dividend
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Div 72,463 41,446 41,188 35,296 50,261 97,382 48,140 7.05%
  YoY % 74.83% 0.63% 16.69% -29.77% -48.39% 102.29% -
  Horiz. % 150.52% 86.09% 85.56% 73.32% 104.41% 202.29% 100.00%
Div Payout % 77.22 % 75.08 % 66.74 % 67.67 % 165.42 % 161.79 % 80.19 % -0.63%
  YoY % 2.85% 12.50% -1.37% -59.09% 2.24% 101.76% -
  Horiz. % 96.30% 93.63% 83.23% 84.39% 206.29% 201.76% 100.00%
Equity
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Net Worth 525,351 486,672 472,037 514,153 421,262 431,217 388,298 5.16%
  YoY % 7.95% 3.10% -8.19% 22.05% -2.31% 11.05% -
  Horiz. % 135.30% 125.33% 121.57% 132.41% 108.49% 111.05% 100.00%
NOSH 258,794 258,868 117,715 117,655 106,919 107,001 106,969 15.86%
  YoY % -0.03% 119.91% 0.05% 10.04% -0.08% 0.03% -
  Horiz. % 241.93% 242.00% 110.05% 109.99% 99.95% 100.03% 100.00%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin 4.44 % 2.92 % 3.49 % 3.47 % 2.20 % 4.75 % 4.70 % -0.94%
  YoY % 52.05% -16.33% 0.58% 57.73% -53.68% 1.06% -
  Horiz. % 94.47% 62.13% 74.26% 73.83% 46.81% 101.06% 100.00%
ROE 17.86 % 11.34 % 13.07 % 10.14 % 7.21 % 13.96 % 15.46 % 2.43%
  YoY % 57.50% -13.24% 28.90% 40.64% -48.35% -9.70% -
  Horiz. % 115.52% 73.35% 84.54% 65.59% 46.64% 90.30% 100.00%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
RPS 820.32 751.98 1,539.60 1,292.74 1,289.15 1,215.67 1,220.58 -6.41%
  YoY % 9.09% -51.16% 19.10% 0.28% 6.04% -0.40% -
  Horiz. % 67.21% 61.61% 126.14% 105.91% 105.62% 99.60% 100.00%
EPS 36.26 21.32 52.42 44.33 28.42 56.25 56.12 -7.02%
  YoY % 70.08% -59.33% 18.25% 55.98% -49.48% 0.23% -
  Horiz. % 64.61% 37.99% 93.41% 78.99% 50.64% 100.23% 100.00%
DPS 28.00 16.01 35.00 30.00 47.00 91.00 45.00 -7.60%
  YoY % 74.89% -54.26% 16.67% -36.17% -48.35% 102.22% -
  Horiz. % 62.22% 35.58% 77.78% 66.67% 104.44% 202.22% 100.00%
NAPS 2.0300 1.8800 4.0100 4.3700 3.9400 4.0300 3.6300 -9.23%
  YoY % 7.98% -53.12% -8.24% 10.91% -2.23% 11.02% -
  Horiz. % 55.92% 51.79% 110.47% 120.39% 108.54% 111.02% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
RPS 162.16 148.70 138.44 116.18 105.29 99.36 99.73 8.44%
  YoY % 9.05% 7.41% 19.16% 10.34% 5.97% -0.37% -
  Horiz. % 162.60% 149.10% 138.81% 116.49% 105.58% 99.63% 100.00%
EPS 7.17 4.22 4.71 3.98 2.32 4.60 4.59 7.71%
  YoY % 69.91% -10.40% 18.34% 71.55% -49.57% 0.22% -
  Horiz. % 156.21% 91.94% 102.61% 86.71% 50.54% 100.22% 100.00%
DPS 5.54 3.17 3.15 2.70 3.84 7.44 3.68 7.05%
  YoY % 74.76% 0.63% 16.67% -29.69% -48.39% 102.17% -
  Horiz. % 150.54% 86.14% 85.60% 73.37% 104.35% 202.17% 100.00%
NAPS 0.4013 0.3718 0.3606 0.3927 0.3218 0.3294 0.2966 5.17%
  YoY % 7.93% 3.11% -8.17% 22.03% -2.31% 11.06% -
  Horiz. % 135.30% 125.35% 121.58% 132.40% 108.50% 111.06% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Date 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 -
Price 4.5800 4.4500 8.1000 5.3600 5.3100 4.0000 3.3600 -
P/RPS 0.56 0.59 0.53 0.41 0.41 0.33 0.28 12.24%
  YoY % -5.08% 11.32% 29.27% 0.00% 24.24% 17.86% -
  Horiz. % 200.00% 210.71% 189.29% 146.43% 146.43% 117.86% 100.00%
P/EPS 12.63 20.87 15.45 12.09 18.69 7.11 5.99 13.23%
  YoY % -39.48% 35.08% 27.79% -35.31% 162.87% 18.70% -
  Horiz. % 210.85% 348.41% 257.93% 201.84% 312.02% 118.70% 100.00%
EY 7.92 4.79 6.47 8.27 5.35 14.06 16.70 -11.69%
  YoY % 65.34% -25.97% -21.77% 54.58% -61.95% -15.81% -
  Horiz. % 47.43% 28.68% 38.74% 49.52% 32.04% 84.19% 100.00%
DY 6.11 3.60 4.32 5.60 8.85 22.75 13.39 -12.25%
  YoY % 69.72% -16.67% -22.86% -36.72% -61.10% 69.90% -
  Horiz. % 45.63% 26.89% 32.26% 41.82% 66.09% 169.90% 100.00%
P/NAPS 2.26 2.37 2.02 1.23 1.35 0.99 0.93 15.94%
  YoY % -4.64% 17.33% 64.23% -8.89% 36.36% 6.45% -
  Horiz. % 243.01% 254.84% 217.20% 132.26% 145.16% 106.45% 100.00%
Price Multiplier on Announcement Date
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Date 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 27/02/09 -
Price 5.2800 4.2900 7.8000 5.9000 5.3500 4.0500 2.7300 -
P/RPS 0.64 0.57 0.51 0.46 0.42 0.33 0.22 19.47%
  YoY % 12.28% 11.76% 10.87% 9.52% 27.27% 50.00% -
  Horiz. % 290.91% 259.09% 231.82% 209.09% 190.91% 150.00% 100.00%
P/EPS 14.56 20.12 14.88 13.31 18.83 7.20 4.86 20.06%
  YoY % -27.63% 35.22% 11.80% -29.31% 161.53% 48.15% -
  Horiz. % 299.59% 413.99% 306.17% 273.87% 387.45% 148.15% 100.00%
EY 6.87 4.97 6.72 7.51 5.31 13.89 20.56 -16.69%
  YoY % 38.23% -26.04% -10.52% 41.43% -61.77% -32.44% -
  Horiz. % 33.41% 24.17% 32.68% 36.53% 25.83% 67.56% 100.00%
DY 5.30 3.73 4.49 5.08 8.79 22.47 16.48 -17.22%
  YoY % 42.09% -16.93% -11.61% -42.21% -60.88% 36.35% -
  Horiz. % 32.16% 22.63% 27.25% 30.83% 53.34% 136.35% 100.00%
P/NAPS 2.60 2.28 1.95 1.35 1.36 1.00 0.75 23.01%
  YoY % 14.04% 16.92% 44.44% -0.74% 36.00% 33.33% -
  Horiz. % 346.67% 304.00% 260.00% 180.00% 181.33% 133.33% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Health minister: Traveller from South Africa on Nov 19 is Malaysia’s first Omicron case save malaysia!
2. WHO urges Asia-Pacific to ready for Omicron-driven surge in infections Good Articles to Share
3. The case of ATA IMS: A tip of the iceberg? By Veeriah save malaysia!
4. 3QCY21 Results Review - Fat Tails Kenanga Research & Investment
5. Aurelius Technologies Bhd - Global EMS Provider PublicInvest Research
6. Strategy - A decent 3Q2021 but uncertainty has increased AmInvest Research Reports
7. MIDF Research maintains 'buy' recommendation on FGV, target price unchanged at RM2.20 (FANTASTIC: ALL PALM OIL STOCKS SHOULD RE RERATED, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
8. Latest Land Disposal in Sg Tiram, Johor, shows Palm Oil Companies with Huge Landbanks with Cheap Book Value are Jewels, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

362  474  546  892 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VSOLAR 0.015-0.005 
 VS 1.15-0.27 
 THHEAVY 0.015-0.05 
 VS-WB 0.355-0.09 
 IMPIANA 0.085+0.005 
 INARI 3.87-0.23 
 GOCEAN 0.0350.00 
 DNEX 0.745-0.025 
 ATAIMS 0.445+0.035 
 EAH 0.02+0.005 
PARTNERS & BROKERS